Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
Summary: The molecular manifestations of host cells responding to SARS-CoV-2 and its evolving variants of infection are vastly different across the studied models and conditions, imposing challenges for host-based antiviral drug discovery. Based on the postulation that antiviral drugs tend to revers...
Main Authors: | Jing Xing, Rama Shankar, Meehyun Ko, Keke Zhang, Sulin Zhang, Aleksandra Drelich, Shreya Paithankar, Eugene Chekalin, Mei-Sze Chua, Surender Rajasekaran, Chien-Te Kent Tseng, Mingyue Zheng, Seungtaek Kim, Bin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222013402 |
Similar Items
-
Systems-wide view of host-pathogen interactions across COVID-19 severities using integrated omics analysis
by: Mairembam Stelin Singh, et al.
Published: (2024-03-01) -
Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV
by: Nadira Vadaq, et al.
Published: (2022-10-01) -
Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
by: Nilesh Kumar, et al.
Published: (2020-09-01) -
Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma
by: Yifei Shen, et al.
Published: (2023-02-01) -
Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
by: Deepti Maheshwari, et al.
Published: (2022-06-01)